Hangzhou JINLAN Pharm-Drugs Technology Co., LIMITED.

In the fields of diabetes and obesity treatment, semaglutide (Semaglutide) is a "double champion" - it is both a "long-acting guardian" for blood sugar control and a "star drug" for weight loss. As an upgraded version of GLP-1 receptor agonists, semaglutide has quickly become a global best-selling drug due to its convenience of "one injection per week" and significant cardiovascular benefits.